Adverse effects of honey on low-density lipoprotein cholesterol and adiponectin concentrations in patients with type 2 diabetes: a randomized controlled cross-over trial

[1] Patel C(2015)Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption FASEB J 29 4046-58

[2] Douard V(2013)Honey as a source of dietary antioxidants: structures, bioavailability and evidence of protective effects against human chronic diseases Curr Med Chem 20 621-38

[3] Yu S(2012)The use of honey in diabetes mellitus: is it beneficial or detrimental? Int J Endocrinol Metab 10 444-5

[4] Gao N(2016)Extraction of honey polyphenols: method development and evidence of Anal Chem Insights 11 49-57

[5] Ferraris RP(2014) isomerization Oxid Med Cell Longev 2014 506948-71

[6] Alvarez-Suarez JM(2016)Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications Phytother Res 30 1559-11

[7] Giampieri F(2018)Non-alcoholic fatty liver disease: beneficial effects of flavonoids Molecules 23 E2220-56

[8] Battino M(2016)Daily consumption of chocolate rich in flavonoids decreases cellular genotoxicity and improves biochemical parameters of lipid and glucose metabolism Int J Obes (Lond) 40 6-72

[9] Erejuwa OO(2016)Physiological handling of dietary fructose-containing sugars: implications for health Diabetes Metab 42 142-94

[10] Istasse T(2015)Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? J Nutr 145 2265-26

[1] Patel C(2015)Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption FASEB J 29 4046-58

[2] Douard V(2013)Honey as a source of dietary antioxidants: structures, bioavailability and evidence of protective effects against human chronic diseases Curr Med Chem 20 621-38

[3] Yu S(2012)The use of honey in diabetes mellitus: is it beneficial or detrimental? Int J Endocrinol Metab 10 444-5

[4] Gao N(2016)Extraction of honey polyphenols: method development and evidence of Anal Chem Insights 11 49-57

[5] Ferraris RP(2014) isomerization Oxid Med Cell Longev 2014 506948-71

[6] Alvarez-Suarez JM(2016)Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications Phytother Res 30 1559-11

[7] Giampieri F(2018)Non-alcoholic fatty liver disease: beneficial effects of flavonoids Molecules 23 E2220-56

[8] Battino M(2016)Daily consumption of chocolate rich in flavonoids decreases cellular genotoxicity and improves biochemical parameters of lipid and glucose metabolism Int J Obes (Lond) 40 6-72

[9] Erejuwa OO(2016)Physiological handling of dietary fructose-containing sugars: implications for health Diabetes Metab 42 142-94

[10] Istasse T(2015)Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? J Nutr 145 2265-26